Studies on oral leukoplakia (OLK) further suggest that BRCA1 and BRCA2 expression levels may distinguish high-risk dysplastic lesions that progress to carcinoma from those that remain benign (42, 54). This evidence concerns the gene BRCA1 and carcinoma.